Monday, August 24, 2026

What Led to the Arrest of a South Korean Student Over North Korean Drone Flights?

A graduate student was denied a detention review after sending drones to North Korea, raising concerns about evidence destruction and flight risks.

Revolutionary Wearable Blood Flow Measurement: How AI and Heat Sensing Technology Are Changing Healthcare

KAIST developed a wireless wearable blood flow measurement system using AI and thermal sensing, enhancing accuracy in health monitoring.

Revolutionary Vector Hologram: How KAIST’s New Technology Elevates Optical Security

A new vector hologram technology can independently control light's polarization and twisting, enhancing optical communication and security.

Tag: AriBio

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Unlocking the Future of Neuroscience: AriBio’s Partnership with Lilly TuneLab for Advanced AI Drug Development

AriBio partners with Eli Lilly's AI platform, Lilly TuneLab, to enhance drug development for neurodegenerative diseases using advanced AI.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

Top News

- Our Sponsors Ad -

Follow us